KYG9495L1251 - Common Stock
VIRAX BIOLABS GROUP LTD
NASDAQ:VRAX (10/28/2024, 8:00:03 PM)
After market: 2.2 -0.01 (-0.45%)2.21
-0.07 (-3.07%)
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.
VIRAX BIOLABS GROUP LTD
Biocity Glasgow, Bo'ness Road, Newhouse
London
P: 4402077887414
Employees: 5
Website: https://www.viraxbiolabs.com
Which stocks are experiencing notable movement on Wednesday?
Discover the most active stocks in Wednesday's session. Stay informed about the stocks that are generating the most trading volume!
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Let's have a look at the gap up and gap down stocks in today's session.
As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Here you can normally see the latest stock twits on VRAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: